Press Room

News / Oct 08, 2019

Celebrating our 60th Anniversary in Cork

10 years in Cork, 60 years in the world.

On September 5th 2019, Hovione celebrated its 60th anniversary at the Cork site in Ireland.

The event joined together team members, clients and stakeholders that make Hovione a great Company.

Guy Villax Simon Coveney Manufacturing Plant Ringaskiddy Cork, Ireland | Hovione
Guy Villax and Simon Coveney, Tánaiste and Minister for Foreign Affairs and Trade of Ireland

 

“I’m delighted to see the Cork site playing such an important part in the success of this impressive company,” said Simon Coveney TD, Tánaiste and Minister for Foreign Affairs and Trade speaking at the celebration event for Hovione’s 60th anniversary.

“Hovione has seen steady growth over the last few years and I’m confident that the coming years will be equally successful for the Cork team.”

 

60th Anniversary in Cork | Hovione
Paul Downing and Simon Coveney, Tánaiste and Minister for Foreign Affairs and Trade of Ireland

 

Celebrating 60th Anniversary in Cork | Hovione
Photo Group
60th Anniversary in Cork | Hovione
Ambassador of Portugal in Ireland, Miguel de Almeida e Sousa, Guy Villax and Paul Downing

 

“Our Cork site plays a significant and strategic role within the Hovione network,” said Hovione CEO, Guy Villax. “With two Active Pharmaceutical Ingredient facilities alongside a Drug Product Intermediate facility that houses the largest commercial pharmaceutical spray dryer in operation, the Cork site boasts both extensive manufacturing capacity and people capability.”

 

Guy Villax Paul Downing at Manufacturing Plant in Cork Ireland | Hovione
Guy Villax, Paul Downing and a Cork tree from Portugal in Cork

 

 

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025